| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/06/2005 | CA2538131A1 Novel triarylimidazoles |
| 05/05/2005 | US20050096489 Mixing an active fluorinating agent selected fromCuF2, AgF, HgF2, TeF4, MnF4, FeF3, and CoF2-4 with at least one support selected from activated carbon, ZnF2, CaF2, MgF2, AlF3, with an aromatic or chloroaromatic compound, heating for fluorination |
| 05/05/2005 | US20050096478 Derivatives of fluoro(hydro)carbons attached to an -alkylene-oxy-carbonyl-leaving group; reactive with amine-containing compounds to form a fluoro-substituted carbamyl protective group useful for the efficient separation, recovery and purification of synthsized organic compounds; libraries |
| 05/05/2005 | US20050096477 Astaxanthin esters |
| 05/05/2005 | US20050096471 Process for producing biaryl compound |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096387 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 05/05/2005 | US20050096362 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096356 2-[[6-Methoxy-3-pyridinyl]methyl]amino-N-[3-(trifluoromethyl)phenyl]benzamide hydrochloride salt or its tautomer; treating retinopathy or age-related macula degeneration |
| 05/05/2005 | US20050096337 for example (2-(3-methoxy-propyl)-4-{methyl-[2-methyl-6-(4-trifluoromethyl-phenyl)-pyridin-3-ylmethyl]-amino}-phenoxy)-acetic acid; Peroxisome Proliferator Activated Receptor (PPAR) activators; treating diabetes, dyslipidemia, cardiovascular disorders, polycystic ovary syndrome, proliferative disorders |
| 05/05/2005 | US20050096336 Benzannelated derivatives, their manufacture and use as pharmaceutical agents |
| 05/05/2005 | US20050096253 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/05/2005 | US20050095457 Iridium complexes in electron transport layer of Light-emitting diodes; bright, efficient, stable; low temperature vacuum deposition and preventing decomposition |
| 05/05/2005 | US20050095204 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 05/05/2005 | US20050095203 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 05/05/2005 | US20050095202 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1528057A1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of HIV infection |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527052A1 3-heterocyclyl substituted benzoic acid derivatives |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | CN1612861A Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 05/04/2005 | CN1199948C Pyridine derivatives, its preparing process and use as berbicide intemrediate |
| 05/04/2005 | CN1199947C Process for production of pyridine derive |
| 05/04/2005 | CN1199931C Naphthalene alizarine derivatives, preparing method and use thereof |
| 05/03/2005 | US6888032 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 05/03/2005 | US6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 05/03/2005 | US6887903 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/03/2005 | US6887890 For therapy of thrombocytopenia |
| 05/03/2005 | US6887886 Therapeutic compositions comprising excess enantiomer |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 05/03/2005 | CA2114114C Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| 04/28/2005 | WO2005038442A1 Method of measuring surface plasmon resonance and noble metal compound for use in the method |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | WO2005037794A1 Cyclohexene compounds |
| 04/28/2005 | WO2005037793A1 Cyclopentene compounds |
| 04/28/2005 | WO2005037786A1 Heterocyclyl compounds |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037763A1 Phenoxyether derivatives as ppar modulators |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037208A2 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005019163A3 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 04/28/2005 | WO2005000232A3 Six membered amino-amide derivatives as angiogenesis inhibitors |
| 04/28/2005 | WO2004092125A3 Using alkylmetal reagents for directed metalation of azaaromatics |
| 04/28/2005 | WO2004089293A3 Hydroxamic acid compounds and methods of use thereof |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090555 Compound for the treatment of metabolic disorders |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/28/2005 | US20050090479 transition metal complexes that can mediate direct and specific strand scission targeted to a single base with a significantly high level of recognition such that cleavage occurs at a limited number of sites along a target polynucleotide; antitumor agents |
| 04/28/2005 | US20050086747 E.g., 2-[(3-amino-6-methoxy-2-pyridyl)methylamino]ethanol; these couplers give strong colorations in varied shades that are uniform from the root to the end of the hairs, that show little selectivity and particularly good resistance, and that have good chromaticity |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542742A1 Method for measuring a surface plasmon resonance and noble metal compound used for the same |
| 04/28/2005 | CA2541751A1 Phenoxyether derivatives as ppar modulators |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1526128A2 Process the preparation of alpha-hydroxycarboxylic acid amides |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525181A1 Process for the preparation of phenylalanine enamide derivatives |
| 04/27/2005 | EP1525180A2 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 04/27/2005 | EP1524980A1 Phenylalanine enamide derivatives containing a spiro[3.5]non-1-ene ring for use as integrin inhibitors |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 04/27/2005 | EP1143974B1 Pharmaceutical compositions for alleviating discomfort |
| 04/27/2005 | EP1056458B1 Treatment of chronic pain |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP0968181B1 Perfluorynated sulphone salts, and their uses as ionic conduction materials |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610669A Heteroaryl-substituted aminocyclohexane derivatives |
| 04/27/2005 | CN1610668A Substituted propane-1, 3-diamine derivatives and the pharmaceutical use |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1198839C Novel dipeptide amidines as thrombin inhibitors |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198802C Chalcones having antiproliferactive activity |
| 04/27/2005 | CN1198606C Benzoyl urea derivatrives injectable preparation and preparing method and their use |
| 04/27/2005 | CN1198574C Novel coupler for use in oxidative hair dyeing |
| 04/26/2005 | US6884876 Disperse-reactive dyes containing acetoxyethylsulfone or vinylsulfone and their process |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |